P671: TREATMENT SEQUENCES AND OUTCOMES OF PATIENTS WITH CLL TREATED WITH TARGETED AGENTS IN REAL-WORLD SETTINGS. (23rd June 2022)

• Record Type: Journal Article
• Authors: Mato, A. R.; Manzoor, B. S.; Coombs, C. C.; Lamanna, N.; Tuncer, H. H.; Brown, J. R.; Roeker, L. E.; Shadman, M.; Allan, J. N.; Ujjani, C.; Eichhorst, B.; Leslie, L.; Fleury, I.; Alhasani, H.; Rhodes, J.; Hill, B. T.; Barr, P. M.; Skarbnik, A.; Davids, M. S.; Bannerji, R.; Fuldeore, M.; Lansigan, F.; Schuh, A.; Pearson, L.; Fox, C. P.; Pivneva, I.; Popadic, L.; Guerin, A.; Eyre, T. A.
• Is Part Of: HemaSphere. Volume 6(2022)Supplement 3
• Page Start: 569
• Page End: 570
• Publication Date: 2022-06-23
• Subjects: Hematology -- Periodicals; 616.15005
• DOI: 10.1097/01.HS9.0000845568.56124.1b
• Languages: English
• ISSNs: 2572-9241